Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
37.47
+1.71 (4.78%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Astrana Health Revenue
Astrana Health had revenue of $972.52M in the quarter ending June 30, 2026, with 48.52% growth. This brings the company's revenue in the last twelve months to $972.52M, down -59.80% year-over-year. In the year 2025, Astrana Health had annual revenue of $3.18B with 56.39% growth.
Revenue (ttm)
$972.52M
Revenue Growth
-59.80%
P/S Ratio
0.48
Revenue / Employee
$1,281,398
Employees
3,000
Market Cap
1.84B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.18B | 1.15B | 56.39% |
| Dec 31, 2024 | 2.03B | 647.88M | 46.72% |
| Dec 31, 2023 | 1.39B | 242.50M | 21.19% |
| Dec 31, 2022 | 1.14B | 370.25M | 47.84% |
| Dec 31, 2021 | 773.92M | 86.74M | 12.62% |
| Dec 31, 2020 | 687.18M | 126.56M | 22.58% |
| Dec 31, 2019 | 560.62M | 40.71M | 7.83% |
| Dec 31, 2018 | 519.91M | 163.55M | 45.90% |
| Dec 31, 2017 | 356.36M | 50.42M | 16.48% |
| Dec 31, 2016 | 305.93M | - | - |
| Mar 31, 2016 | - | - | - |
| Mar 31, 2015 | - | - | - |
| Jan 31, 2014 | - | - | - |
| Jan 31, 2013 | - | - | - |
| Jan 31, 2012 | - | - | - |
| Jan 31, 2011 | 3.90M | 1.46M | 59.60% |
| Jan 31, 2010 | 2.44M | 1.38M | 130.90% |
| Jan 31, 2009 | 1.06M | -89.44M | -98.83% |
| Jan 31, 2008 | 90.50M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ardent Health | 6.41B |
| agilon health | 5.92B |
| AMN Healthcare Services | 3.43B |
| Surgery Partners | 3.37B |
| Aveanna Healthcare Holdings | 2.52B |
| Pediatrix Medical Group | 1.95B |
| Healthcare Services Group | 1.86B |
| Addus HomeCare | 1.48B |
ASTH News
- 15 hours ago - Astrana Health price target raised to $55 from $47 at Truist - TheFly
- 4 days ago - Astrana Health price target raised to $53 from $50 at Barclays - TheFly
- 4 days ago - Astrana Health Earnings Call Transcript: Q2 2026 - Transcripts
- 4 days ago - Astrana Health Earnings release: Q2 2026 - Filings
- 4 days ago - Astrana Health Slides: Q2 2026 - Filings
- 4 days ago - Astrana Health Quarterly report: Q2 2026 - Filings
- 4 days ago - Astrana Health sees 2026 revenue $3.8B-$4.1B, consensus $4.0B - TheFly
- 4 days ago - Astrana Health reports Q2 EPS 80c vs. 55c last year - TheFly